Opus Genetics Announces $1.7 Million in Project-based Funding from the[...]
Opus Genetics Receives Rare Pediatric Disease Designation from the U.S.[...]
10/22/2024 | Press release | Archived content
Please select the service you want to use:
Smartlinks | Opus Genetics Inc. | News | Health | Science | Biology | Finance | Security Markets | Security Markets | Company News | Top Company News | Corporate Debt | Pharmaceuticals | Biotechnology and Medical Research Companies | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Nasdaq Capital Market | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | FINRA Alternative Display Facility (ADF) | Nasdaq BX | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact